International ME/CFS Conference 2025 Berlin May 12-13

Just noticed that all patients in the trial were female. Wonder if there are diseases with very different responses to meds between males and females?
 
I'm not sure when the videos will become available but I'd also highlight Dr Anna Aschenbrenner's talk that came at the end of day 1. Data from paper in preparation.

Using high-dimensional flow cytometry, they showed changes in NKs. However, they could not find a difference in immune cell subtypes when looking at subgroups based on causative infection (SARS2, EBV, influenza etc). And defined two severity subsets based on transcriptome.

0 copy.jpg 1 copy.jpg 2 copy.jpg 3 copy.jpg 4 copy.jpg
 
Back
Top